Bicycle Therapeutics PLC (BCYC)

NASDAQ: BCYC · IEX Real-Time Price · USD
17.49
+0.71 (4.23%)
At close: Jul 1, 2022 4:00 PM
17.25
-0.24 (-1.37%)
After-hours: Jul 1, 2022 5:34 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Revenue
11.710.3913.87.142.06
Revenue Growth (YoY)
12.58%-24.72%93.40%246.41%-
Gross Profit
11.710.3913.87.142.06
Selling, General & Admin
32.4429.214.568.126.41
Research & Development
44.8833.1525.5420.7611.87
Operating Expenses
77.3262.3540.128.8818.27
Operating Income
-65.62-51.96-26.3-21.75-16.21
Interest Expense / Income
2.980.46000
Other Expense / Income
-0.12-0.684.560.50.07
Pretax Income
-68.48-51.73-30.86-22.24-16.28
Income Tax
-1.66-0.72-0.25-0.4-0.02
Net Income
-66.82-51.01-30.61-21.85-16.26
Net Income Common
-66.82-51.01-30.61-21.85-16.26
Shares Outstanding (Basic)
25191100
Shares Outstanding (Diluted)
25191100
Shares Change
30.90%73.34%2416.82%31.74%-
EPS (Basic)
-2.67-2.66-2.77-49.78-48.81
EPS (Diluted)
-2.67-2.66-2.77-49.78-48.81
Free Cash Flow Per Share
-0.67-0.99-2.73-62.12-7.59
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-560.98%-500.10%-190.56%-304.74%-787.04%
Profit Margin
-571.25%-490.95%-221.78%-306.14%-789.27%
Free Cash Flow Margin
-143.83%-182.76%-218.59%-382.06%-122.72%
Effective Tax Rate
2.43%1.40%0.82%1.78%0.14%
EBITDA
-64.09-50-29.9-21.53-15.95
EBITDA Margin
-547.91%-481.23%-216.67%-301.71%-774.27%
Depreciation & Amortization
1.411.280.960.710.33
EBIT
-65.5-51.28-30.86-22.24-16.28
EBIT Margin
-559.96%-493.52%-223.62%-311.69%-790.39%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).